Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Trovagene Inc

+ Add to Watchlist

TROV:US

10.9300 USD 0.6400 6.22%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Trovagene Inc (TROV)

Open: 10.0400 Day's Range: 10.0000 - 10.9900 Volume: 419,921
Previous Close: 10.2900 52wk Range: 2.9700 - 11.6800 1-Yr Rtn: +207.89%

Stock Chart for TROV

No chart data available.
  • TROV:US 10.9300
  • 1D
  • 1M
  • 1Y
10.2900
Interactive TROV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TROV

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.9483
Est. EPS (USD) (12/2015) -1.0130
Est. PEG Ratio -
Market Cap (M USD) 267.29
Shares Outstanding (M) 24.46
30 Day Average Volume 567,892
Price/Book (mrq) 11.5730
Price/Sale (ttm) 740.9806
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TROV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TROV

Trovagene, Inc. is an applied genomics company. The Company is developing a non-invasive testing technology using transrenal nucleic acid (TrNA) markers for infectious diseases, prenatal testing, early detection of cancer, and monitoring of organ and cell transplantation.

Antonius P Schuh "Tony"Chief Executive OfficerStephen L Zaniboni "Steve"Chief Financial Officer
Mark ErlanderChief Scientific OfficerMatthew L Posard "Matt"Exec VP/Chief Commercial Ofcr
More Company Profile & Key Executives for TROV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil